Area of research
Infectious Diseases · Microbiology
Research interest
Research interests include HIV/AIDS Research and Interventions, Reproductive tract infections research, Syphilis Diagnosis and Treatment, and HIV, Drug Use, Sexual Risk.
Doxycycline Postexposure Prophylaxis and Sexually Transmitted Infection Trends
Doxycycline to prevent bacterial sexually transmitted infections in the USA: final results from the DoxyPEP multicentre, open-label, randomised controlled trial and open-label extension
Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trial
Impact of doxycycline post-exposure prophylaxis for sexually transmitted infections on the gut microbiome and antimicrobial resistome
Doxycycline as Postsexual Exposure Prophylaxis: Use, Acceptability, and Associated Sexual Health Behaviors Among a Multi-Site Sample of Clinical Trial Participants
Rapid biphasic decay of intact and defective HIV DNA reservoir during acute treated HIV disease
Near-Universal Resistance to Macrolides of <i>Treponema pallidum</i> in North America
Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections
Selective Whole-Genome Amplification as a Tool to Enrich Specimens with Low Treponema pallidum Genomic DNA Copies for Whole-Genome Sequencing
Acute HIV at the Time of Initiation of Pre-exposure or Post-exposure Prophylaxis: Impact on Drug Resistance and Clinical Outcomes
Coronavirus Disease 2019 Outbreak in a San Francisco Homeless Shelter
Lessons From Mass-Testing for Coronavirus Disease 2019 in Long-Term Care Facilities for the Elderly in San Francisco
Outcomes of Contact Tracing in San Francisco, California—Test and Trace During Shelter-in-Place
Quarterly screening optimizes detection of sexually transmitted infections when prescribing HIV preexposure prophylaxis
Brief Report: Short-Term Adherence Marker to PrEP Predicts Future Nonretention in a Large PrEP Demo Project: Implications for Point-of-Care Adherence Testing
Acquisition of tenofovir-susceptible, emtricitabine-resistant HIV despite high adherence to daily pre-exposure prophylaxis: a case report
Patterns and Correlates of Participant Retention in a Multi-City Pre-Exposure Prophylaxis Demonstration Project
HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study
Hair levels of preexposure prophylaxis drugs measure adherence and are associated with renal decline among men/transwomen
Changes in Kidney Function Associated With Daily Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Preexposure Prophylaxis Use in the United States Demonstration Project
Body/Selves and Beyond: Men’s Narratives of Sexual Behavior on PrEP
Healthcare Access and PrEP Continuation in San Francisco and Miami After the US PrEP Demo Project
Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services
Sexual Behavior, Risk Compensation, and HIV Prevention Strategies Among Participants in the San Francisco PrEP Demonstration Project: A Qualitative Analysis of Counseling Notes
Lymphogranuloma Venereum 2015: Clinical Presentation, Diagnosis, and Treatment: Table 1.
Antiretroviral pre‐exposure prophylaxis implementation in the United States: a work in progress
Clinical Treatment Options Infectious Diseases: Update on PrEP Implementation, Adherence, and Advances in Delivery
The incidence of<i>Trichomonas vaginalis</i>infection in women attending nine sexually transmitted diseases clinics in the USA: Table 1
Early Experiences Implementing Pre-exposure Prophylaxis (PrEP) for HIV Prevention in San Francisco